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Hyperglycemia worsens ischemic injury in several 
ischemic models. To determine whether renal lactate ac- 
cumulation was associated with hyperglycemia-exacer- 
bated postischemic renal dysfunction and mortality, 
halothane-anesthetized rats underwent right nephrec- 
tomy and 45 min of left renal artery and vein occlusion. 
Prior to ischemia, rats received saline (n = 22), glucose 
(2 g/kg, n = 22), or insulin (4 U/kg, n = 18). Sham-op- 
erated glucose-treated rats (2 g/kg, n = 4) underwent 
right nephrectomy and no vascular occlusion. As antic- 
ipated, glucose pretreatment elevated plasma glucose, 
while insulin pretreatment lowered plasma glucose; both 
were significantly different from values in saline con- 
trols. Creatinine was unchanged in sham-operated rats 
but was significantly higher in glucose-treated rats at 24 
and 48 hr postischemia compared to saline controls. No 
statistical differences in creatinine were found when 
comparing saline controls to insulin-treated rats. Eigh- 
teen percent of glucose-treated rats survived to 72 hr 
postocclusion, while 45% of insulin-treated rats, 73% of 
saline control rats, and 100% of sham-operated rats sur- 
vived this period. In a separate but identical treatment 
protocol, renal tissue was serially sampled and lactate 
content was determined in rats pretreated with saline (n 
= 7), glucose (n = 6) or insulin (n = 6) or sham-operated 
(n = 2) and receiving identical operation. Tissue lactate 
concentration did not change during serial sampling in 
the sham group. During ischemia, lactate was signifi- 
cantly higher in glucose-treated rats and significantly 
lower in insulin-treated rats as compared to saline con- 
trols. The adverse effects of exogenous glucose and at- 
tendant hyperglycemia on renal function during nor- 
mothermic renal ischemia are demonstrated. Increased 
anaerobic metabolism of glucose with marked lactate ac- 
cumulation may increase the severity of injury. However, 
a direct link between tissue lactate and ischemic damage 
is not fully supported since insulin reduced renal lactate 
but failed to lessen morbidity and mortality. o 1989 Academic 
Press, Inc. 
INTRODUCTION 
Renal ischemia predictably accompanies a number of 
common operations, including renal transplantation and 
complex aortic reconstructions, and continues to con- 
tribute significantly to postoperative acute renal failure 
with high attendant mortality [l-4]. The pathophysiologic 
processes that lead to renal tubular cell death and epi- 
thelial disruption, however, remain poorly understood. 
Recent experimental work has focused on the influence 
of metabolic substrate provision in the ischemic tissue. 
Numerous animal and clinical studies have shown that 
hyperglycemia in the setting of ischemia will enhance 
ischemic damage [5-281. These investigations have fo- 
cused primarily on hyperglycemia-exacerbated morbidity 
and mortality in acute cerebral ischemia. However, a re- 
cent demonstration of adverse consequences from exog- 
enous glucose provision in renal ischemia in dogs suggests 
the need for further study of hyperglycemia-exacerbation 
of noncentral nervous system tissue injury [29]. 
The most widely hypothesized mechanism of hypergly- 
cemia-exacerbated ischemic injury holds that during 
ischemia the cell undergoes rapid depletion of high energy 
stores and a shift from aerobic to anaerobic glycolysis 
with accumulation of its end product, lactate. Intracellular 
lactate accumulates, contributing to secondary compro- 
mise of cellular function [8,14,25-271. We explored these 
initial alterations in carbohydrate metabolism in a rat 
model of normothermic renal ischemia. Two hypotheses 
were proposed: (1) hyperglycemia with increased metab- 
olism of glucose to lactate exacerbates renal ischemic 
damage, and (2) insulin-induced reduction of glucose 
availability with limited lactate accumulation will ame- 
liorate damage. 
METHODS 
Two discrete protocols were utilized. They were iden- 
tical in every respect except that in the first functional 
endpoints and survival were assessed over a 72-hr post- 
ischemia period, while the second utilized tissue biopsy 
for lactate assay. The use of two protocols obviates any 
concern that the multiple biopsies influenced functional 
outcomes. All procedures were approved by and followed 
the guidelines of the Unit for Laboratory Animal Medicine 
(ULAM) of The University of Michigan Medical School. 
0022-4804/89 $1.50 
Copyright 0 1989 by Academic Press, Inc. 
All rights of reproduction in any form reserved. 
512 
PODRAZIK ET AL.: LACTATE ACCUMULATION IN ACUTE RENAL ISCHEMIA 573 
Functional protocol. Adult male Sprague-Dawley rats, 
weighing 270-330 g, were individually housed with free 
access to standard rodent chow and water. Ambient tem- 
perature was 26-27°C and 12 hour light/dark cycles were 
preserved. Approximately half of the experimental ani- 
mals were maintained in metabolic cages. Following a 24- 
to 36-hr acclimation period, a 24-hr baseline urine output 
was determined. Baseline plasma glucose and creatinine 
concentrations were determined spectrophotometrically 
(Ames Seralyzer) prior to halothane anesthesia (or prior 
to insulin pretreatment). 
Rats were randomly assigned to one of four treatment 
groups. Treatment solutions were administered by intra- 
peritoneal (ip) injection immediately after anesthetic in- 
duction. Glucose-treated animals (n = 22) received an 
isoosmotic solution (2 g/kg). Ischemic control animals (n 
= 22) received saline (isovolumetric to the glucose-treated 
group). A third group (n = 18) received insulin (Lilly), 4 
U/kg, by subcutaneous injection 45 min prior to anesthetic 
induction and isovolumetric saline after induction. Sham- 
operated (nonischemic) controls (n = 4) received 2 g/kg 
glucose, underwent the surgical and recovery procedures 
described below, but received no renal pedicle occlusion. 
Anesthesia (1.5% chamber induction; 0.75% mask 
maintenance) was used and normothermia (37°C) was 
maintained with a thermal pad and external heat sources 
and continuously monitored via a rectal probe. The kid- 
neys were approached via bilateral flank incisions. Right 
nephrectomy was performed. The left renal artery and 
vein were isolated and encircled with a snare of polyeth- 
ylene tubing (PE 10 in a sheath of PE 160) tunnelled to 
dorsal midline and brought out through a stab wound. 
The snare was tightened and secured for 45 min and the 
animals were allowed to awaken. The polyethylene snare 
permitted occlusion and release in the awake animal with 
reliable reperfusion. (In the first experiments utilizing this 
modification, snare release and confirmation of reperfu- 
sion were performed under direct vision during a second 
brief period of halothane anesthesia. Doppler ultrasound 
confirmation of reperfusion was also obtained.) Animals 
were recovered with free access to food and water for 72 
hr after occlusion. 
During the recovery period, plasma glucose was deter- 
mined at 4 hr and plasma creatinine was measured at 24, 
48, and 72 hr postischemia. Urine was collected at 24-hr 
intervals. Urine osmolarity was determined daily (Roeb- 
ling Osmometer). Animals surviving the 72-hr recovery 
period were evaluated under anesthesia to again verify 
reperfusion and then euthanized by halothane overdose. 
Postmortem examinations were performed on all animals 
that died prior to 72 hr. 
Biopsy protocol. In a separate experiment, renal tissue 
was obtained for lactate analysis from animals assigned 
to the described treatment groups. A pneumatic biopsy 
drill with a 3-mm bore (Alko Diagnostic Corp.) provide 
quick tissue removal in conjunction with immediate 
freezing [30]. The operation described previously was uti- 
lized except the right kidney was approached first. A 
baseline tissue sample was obtained from the right kidney 
followed by immediate nephrectomy. Renal tissue (50-75 
mg) from the left kidney at the corticomedullary junction 
at the midupper and midlower poles was obtained at 20 
and 45 min of ischemia. Following snare release, reper- 
fusion was again confirmed visually and by Doppler ul- 
trasound. Tissue samples were kept in liquid nitrogen un- 
til being ground to a fine powder at -2O’C and then 
transferred to 1 ml of 3 M perchloric acid. After adding 
2 ml distilled water, the samples were centrifuged at 6750g 
and 4°C for 25 min. The supernatant was stored at -7O“C 
until Auorometric lactate analysis with lactate dehydrog- 
enase in a NAD-to-NADH-linked reaction [31]. 
Statistical methods. Baseline within-group values 
were compared to values obtained during the 72-hr ob- 
servation period by paired t test. Baseline between-group 
comparisons of temperature, plasma glucose, and urine 
output were evaluated with one-way analysis of variance 
(ANOVA, cy = 0.05). Comparisons of the means of saline 
control versus insulin-treated and saline control versus 
glucose-treated groups were performed with the Student’s 
t test with the Bonferroni correction for multiple com- 
parisons [32]. All average values are expressed as means 
-t 1 standard error. Survival data for glucose-treated and 
insulin-treated animals were evaluated against saline 
ischemic controls using the Fisher’s exact test and the 
Breslow survival curve analysis [33]. 
RESULTS 
In the results that follow, comparisons were performed 
within each of the four treatment groups and between the 
saline and insulin- or glucose-treated groups. 
Functional protocol. Comparison of the means of 
baseline variables (body weight, rectal temperature, 
plasma glucose, and urine output) by ANOVA or Student’s 
t with Bonferroni correction revealed no statistically sig- 
nificant differences between the treatment groups (Table 
l), except saline-treated rats weighed more than sham- 
operated rats. Significant (P < 0.05) postsurgical weight 
loss occurred in all groups; however, the treatment groups 
did not differ with respect to the degree of weight loss. 
Surgical manipulation alone caused a significant elevation 
in plasma glucose (Fig. 1). Glucose administration sig- 
nificantly augmented this hyperglycemic response. Insulin 
administration reduced preocclusion plasma glucose levels 
to 77 + 3 mg/dl, significantly lower than preocclusion 
levels in the saline controls. Plasma glucose concentra- 
tions in sham-operated, glucose-treated rats were identical 
to levels achieved in glucose-treated rats undergoing renal 
pedicle occlusion. By 4 hr postocclusion, there was no 
difference in plasma glucose concentrations between sa- 
line and glucose- or insulin-treated groups (saline, 123 
+ 4 mg/dl; glucose, 124 + 3 mg/dl; insulin, 105 + 6 mg/ 
dl; sham, 135 + 8 mg/dl). 
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TABLE 1 
Baseline Variables: Recovery Protocol 
Saline Glucose Insulin Sham 
(n = 22) (n = 22) (n = 18) (n = 4) 
Body weight (g) 317 + 3 308 + 3 308 f 3 293 + 8’ 
Rectal temperature 
(“C) 36.6 + 0.1 36.5 + 0.1 36.5 + 0.1 36.5 + 0 
Plasma glucose 
bddl) 128 +3 129 + 2 131 + 3 142 f 2 
Urine output 
(ml/kg/day) 43 3~ 712 64 + 10’ 46 ?z 8i” 24 f 3’ 
Note. Values are means + 1 SEM for presurgical body weight, plasma 
glucose, urine output, and prerenal vessel occlusion rectal temperature 
for the functional protocol. Sample sizes are 22 for saline control, 22 
for glucose-treated, 18 for insulin-treated, and 4 for sham-operated, glu- 
cose-treated or as indicated by superscript. Comparison (ANOVA or 
Student’s t test with Bonferroni correction) between saline and glucose 
or insulin treatment reveals no significant difference between these 
variables. 
* Indicates a significant difference (P < 0.05 ANOVA) between saline- 
treated and sham-operated groups. 
Functional parameters, mean daily plasma creatinine 
and urine output, are shown in Table 2 and Fig. 2, re- 









FUNCTIONAL PR OTOCOI 







Baseline Pre-occlusion Pre-reperfusion 
BIOPSY PROTOCOL 
Baseline Pre-occlusion Pre-reperfusion 
FIG. 1. Plasma glucose (mg/dl) at baseline (preanesthesia), preoc- 
elusion anesthetized, and prereperfusion (after 45 min of renal pedicle 
occlusion) time points in insulin-treated (4 U/kg); saline control, glucose- 
treated (2 g/kg); and sham-operated, glucose-treated (2 g/kg) rats. Top 
panel represents results from functional protocol; bottom panel, biopsy 
protocol. **P < 0.001 by Student’s t test with Bonferroni correction. 




Saline Glucose Insulin Sham 
Baseline 0.4 + 0.04 0.4 * 0.04 0.4 -c 0.04 0.5 f 0.02 
n 22 22 18 4 
24 hr 4.7 f 0.1 5.6 3~ 0.2* 5.0 f 0.2 0.8 f 0.1 
n 22 20 18 4 
48 hr 6.1 f 0.4 7.6 f 0.3** 6.6 + 0.5 0.5 f 0.02 
n 15 14 14 4 
72 hr 5.5 + 0.7 5.9 + 1.2 4.8 f 0.8 0.4 f 0.05 
n 16 4 8 4 
Note. Values are means + 1 SEM for plasma creatinine in mg/dl prior 
to renal pedicle occlusion (baseline) and at 24, 48, and 72 hr after oc- 
clusion for saline control, glucose-treated, insulin-treated, and sham 
groups. 
* P < 0.001. 
** P < 0.012 by Student’s t test with Bonferroni correction. 
among the comparison groups. Unilateral nephrectomy 
alone (sham-operated) did not significantly elevate daily 
plasma creatinine. In contrast, 45 min of normothermic 
renal pedicle occlusion produced significant elevation in 
plasma creatinine in all ischemic groups (P < 0.001 by 
paired t analysis). At 24 and 48 hr, plasma creatinine was 
significantly higher in the glucose-treated group compared 
to saline controls. Plasma creatinine tended to be higher 
in insulin-treated animals as compared to saline controls, 
but this difference was not statistically significant. 
A significantly increased urine output was noted in the 
saline control group at 48 and 72 hr (P < 0.04 by paired 
t analysis). In contrast, glucose-treated rats showed sig- 
nificant oliguria at 24 hr compared to baseline values and 
to the saline controls. At 48 hr, two of the five glucose- 
treated animals surviving were polyuric (128 and 95 ml/ 
BSSSlitlS 24 40 72 
HOURS POST-OCCLUSON 
FIG. 2. Daily urine output at baseline and at 24, 48, and 72 hr 
postischemia in insulin-treated (4 U/kg); saline control, glucose-treated 
(2 g/kg); and sham-operated, glucose-treated (2 g/kg) rats. **P < 0.012 
by Student’s t test with Bonferroni correction. Sample sizes are indicated 
at the bottom of each bar. 
PODRAZIK ET AL.: LACTATE ACCUMULATION IN ACUTE RENAL ISCHEMIA 575 
kg), while the remaining three were oliguric (3,4, and 24 
ml/kg). Except for the most polyuric rat, 48hr plasma 
creatinine exceeded 8.5 mg/dl in these glucose-treated 
rats, and only the most polyuric rat lived to 72 hr. 
Baseline urine osmolarity did not differ among saline, 
glucose, and insulin groups. Values of 1442 + 142, 1366 
f 113, 1549 f 141, and 848 f 190 mOsm/liter were ob- 
tained in the saline control (n = 7), glucose-treated (n 
= 8), insulin-treated (n = 9), and sham-operated groups 
(n = 2), respectively. All ischemic groups demonstrated 
significant reduction of concentrating ability postischemia 
(P < 0.05 by paired t analysis), while sham rats did not 
differ significantly from baseline. Concentrating ability 
was markedly reduced in the glucose-treated rats as com- 
pared to saline controls at 24 hr (384 + 32 mOsm/liter vs 
486 f 18 mOsm/liter, P < 0.05). However, this difference 
failed to reach statistical significance at 48 hr (458 + 26 
mOsm/liter vs 537 + 23 mOsm/liter, P = 0.15). Urine 
osmolarity was not different between insulin-treated and 
saline control rats at any postischemic time (451 + 30 
mOsm/liter at 24 hr, 514 f 22 mOsm/liter at 48 hr, and 
637 f 87 mOsm/liter vs 668 f 42 mOsm/liter at 72 hr). 
Survival curves for 72 hr postocclusion are illustrated 
in Fig. 3. The sham-operated group showed no mortality. 
Glucose-treated animals had significantly greater mor- 
tality than saline controls (P = 0.0003 by Fisher’s exact 
test, P = 0.002 by Breslow analysis). Insulin-treated an- 
imals also showed greater mortality at 72 hr as compared 
to saline controls by Fisher’s exact test (P = 0.05); how- 
ever, comparison using Breslow analysis revealed no sig- 
nificant difference in survival (P = 0.44). 
Biopsyprotocol. Comparison of the means of baseline 
variables (body weight, rectal temperature, plasma cre- 
atinine, plasma glucose, and tissue lactate) revealed no 
statistically significant differences between the treatment 
groups (Table 3). The alterations in plasma glucose pro- 





SURVIVAL TIME (hours) 
72 
FIG. 3. Percentage survival for 72-hr recovery period following renal 
pedicle occlusion in insulin-treated (4 U/kg); saline control, glucose- 
treated (2 g/kg); and sham-operated, glucose-treated (2 g/kg) rats. Initial 
sample sizes are 22 for saline control, 22 for glucose-treated, 18 for 
insulin-treated, and 4 for sham-operated, glucose-treated. *P = 0.05 by 
Fisher’s exact test and P = 0.44 by Breslow analysis; **P = 0.0003 by 
Fisher’s exact test and P = 0.002 by Breslow analysis. 
TABLE 3 
Baseline Variables: Biopsy Protocol 
Saline 
(n = 7) 
Glucose Insulin 
(n = 6) (n = 6) 
Sham 
(n = 2) 
Body weight (g) 310 + 11 319 + 12 306 +7 331 f34 
Rectal temperature 
(“C) 36.8 f 0.1 36.7 f 0.1 36.8 + 0.2 37 -c 0 
Plasma creatinine 
bddl) 0.4 f 0.1 0.4 f 0.1 0.4 f 0.1 0.6 31 0.1 
Plasma glucose 
bddl) 126 f 3 124 + 5 131 f 3 137 +- 2 
Tissue lactate 
(rmoleld 1.0 + 0.1 1.1 + 0.1 0.8 + 0.1 0.5 k 0.1 
Note. Values are means f 1 SEM for presurgical body weight, plasma 
creatinine, plasma glucose, and preocclusion rectal temperature for the 
biopsy protocol. Sample sizes are seven for saline control, six for glucose- 
treated, six for insulin-treated, and two for sham-operated, glucose- 
treated. Comparison between saline and glucose or insulin treatment 
reveals no significant differences under these baseline conditions. 
biopsy protocol, seen in Fig. 1. The outcome measure was 
renal tissue lactate. Serial tissue biopsies did not alter 
.renal tissue lactate in the sham-operated group (Fig. 4). 
However, after 20 min of renal pedicle occlusion, renal 
lactate accumulation rose significantly in all groups (P 
< 0.005 by paired t analysis). Renal lactate concentration 
was significantly lower in insulin-treated rats than saline 
controls at both 20 and 45 min after occlusion. Glucose 
pretreatment caused marked renal lactate accumulation 
with statistically higher values at 45 min of ischemia as 
compared to saline controls. 
DISCUSSION 
Renal ischemia continues to play a significant role in 
the pathogenesis of postoperative acute renal failure and 
attendant morbidity and mortality remain high. Under- 
standing of cellular metabolic responses to ischemia re- 
” 
Baseline 20 45 
MINUTES POST-OCCLUSION 
FIG. 4. Renal tissue lactate at baseline and at 20 and 45 min of 
ischemia in pmole/g tissue in insulin-treated (4 U/kg); saline control, 
glucose-treated (2 g/kg); and sham-operated, glucose-treated (2 g/kg) 
rats. *P < 0.0167, **P < 0.001 by Student’s t test with Bonferroni 
correction. Sample sixes are indicated in the figure legend. 
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mains incomplete. Evidence in the experimental literature 
has identified the potential detrimental effect of glucose 
administration in a number of ischemia models and fur- 
ther evidence is provided here. 
Model considerations. A 45-min ischemic period was 
chosen for these studies. A slightly greater increase in 
plasma creatinine was found in this study as compared 
to reports by other investigators using the same model 
[34, 351. Strict maintenance of normothermia may ac- 
count for the difference in postischemic renal function in 
our protocols. 
The level of baseline functional impairment selected is 
important so that adverse and beneficial effects of pro- 
posed interventions can be noted. In our experiment, glu- 
cose administration did result in significant exacerbation 
of renal injury as compared to saline controls. In addition, 
despite significant elevation of plasma creatinine in the 
saline control group (4.7 mg/dl at 24 hr, 6.1 mg/dl at 48 
hr, and 5.5 mg/dl at 72 hr), these controls were polyuric, 
permitting functional assessments based on urinary out- 
put and composition. (By contrast, the severe glucose- 
exacerbated injury was accompanied by marked oliguria.) 
Further, 73% of the saline control group survived the 72- 
hr observation period. In all but one case, this correlated 
with functional recovery as well. Finally, while the specific 
interventions in this experiment did not limit ischemic 
damage, significant protection has been provided using 
this model of renal ischemia in other work from our lab- 
oratory [36]. 
Intravenous glucose solutions are widely used clinically 
and attendant moderate hyperglycemia is common. We 
sought to strictly control the administered glucose load 
to closely parallel a clinically relevant level of hypergly- 
cemia. In addition, isoosmotic solutions were prepared to 
avoid a potentially significant osmotic diuresis and the 
total volume was limited. 
The sham-operated group provided important experi- 
mental control. It is reasonable to conclude that the an- 
esthetic, surgical preparation, unilateral nephrectomy, 
and/or sampling procedures did not significantly impact 
on renal function in the recovery protocol. 
A separate biopsy protocol was used to obtain renal 
tissue for lactate assay. Reproducible lactate levels re- 
quired at least 50 mg of tissue. The ischemic kidney (ap- 
proximately 800-900 mg in size) was biopsied twice. The 
remaining renal tissue showed evidence of reperfusion in 
all cases. The characteristics, preparation, and handling 
of the animals were identical between the two protocols. 
The plasma glucose profiles were also essentially identical 
permitting reasonable comparison between protocols. The 
sham-operated group again provided an important con- 
trol. The pneumatic biopsy drill did not produce wide- 
spread renal tissue injury in that lactate levels on repeated 
biopsy within the same kidney did not vary from the con- 
trol value among the shams. 
Mechanistic considerations. Hyperglycemia-exacer- 
bated renal ischemic damage is again demonstrated in 
this experiment. This concept is well established in the 
cerebral ischemia literature [5-281 and has been previ- 
ously demonstrated by us in experimental canine renal 
ischemia [29]. It is important to note that the detrimental 
effects of hyperglycemia were apparent at far lower plasma 
glucose levels than previously reported [7, 8, 20, 231. In 
these experiments, significant increases in postischemic 
renal dysfunction occurred with plasma glucose levels of 
only 272 f 8 mg/dl. A possible explanation for the ob- 
served deleterious effects of glucose is the differences in 
baseline urine output (as a reflection of preocclusion hy- 
dration status). However, the treatment effects remain 
after appropriately controlling for these differences using 
univariate and multivariate statistical methods. 
In past work, we have demonstrated that the adverse 
effects of hyperglycemia in an ischemic setting require 
continued ischemic metabolism of glucose in order to 
augment postischemic dysfunction. When one inhibits 
continued glucose metabolism in the presence of hyper- 
glycemia, injury is not enhanced. In a model of forebrain 
ischemia, 2-deoxyglucose, a competitive inhibitor of the 
cellular glucose uptake and an inhibitor of glycolytic flux 
(hexokinase), provided marked reduction of postischemic 
neurologic deficit in the face of elevated plasma glucose 
levels [37]. 
Much of the work on the role of lactate accumulation 
in ischemic injury has been performed in models of myo- 
cardial and cerebral ischemia. Numerous studies, includ- 
ing work from our own laboratory, have established that 
hyperglycemia in the setting of cerebral ischemia produces 
functional and morphologic exacerbation of neurologic 
deficit [5-7, 13, 181. Such deficits have often been asso- 
ciated with lactate accumulation [8, 14, 25-271. Previ- 
ously, insulin administration (with presumed reduction 
of lactate) has been found to be protective in models of 
cerebral and spinal cord ischemia [38, 391. Neely and 
Grotyohann also suggest a major role for glycolytic prod- 
ucts in myocardial ischemia [40]. Accumulation of tissue 
lactate during ischemia in the isolated perfused heart 
consistently produced a strong inverse correlation with 
postischemic recovery of ventricular function-an effect 
largely independent of tissue adenine nucleotide levels. 
Interestingly, in Neely’s studies infusion of lactate during 
the reperfusion period was not detrimental, suggesting 
that any predominant harmful effect of lactate was during 
the ischemic interval. Equally compelling is recent evi- 
dence suggesting a diminished role for lactate in cerebral 
ischemic pathophysiology. Cerebral lactate accumulation 
was measured in dogs subjected to cardiac arrest following 
selective brain cooling and in normothermic controls [41]. 
Cerebral hypothermia provided significant reduction of 
postischemic neurologic dysfunction and mortality but 
no differences in cerebral cortical lactate accumulation 
were detected between brain-cooled and control dogs. 
There are a paucity of reports regarding the role of lactate 
in renal ischemia. Vogt and Farber, however, found no 
differences in postischemic renal histopathology in rats 
with tissue lactate reduction following 2-deoxyglucose 
pretreatment as compared to controls [42]. The initial 
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injury, however, was mild and baseline lactate accumu- 
lation low. No functional assessments were obtained. 
In the present study, marked lactate accumulation in 
glucose-treated animals was associated with significant 
exacerbation of postischemic renal dysfunction. However, 
insulin-induced reduction of plasma glucose which caused 
significant reduction of tissue lactate failed to ameliorate 
postischemic injury. The reduction of tissue lactate was 
to levels generally felt to be innocuous to tissues. Thus, 
data from this study do not fully support the hypothesis 
that increased levels of lactate lead to exacerbation of 
renal ischemic damage. 
An alternative explanation of the data has been sug- 
gested in the cerebral ischemia literature. Myers and oth- 
ers have shown that a threshold for cerebral necrosis exists 
at tissue lactate levels of 16-20 pmole/g tissue [16, 431. 
Such a “threshold effect” for lactate could explain these 
data. A further postulate may be that increasing tissue 
lactate concentration may contribute to exacerbation of 
injury by further decreasing tissue pH. Thus, while the 
data verifying hyperglycemia-exacerbated renal ischemic 
damage are compelling, it remains unproved whether lac- 
tate accumulation is the mechanistic link between ob- 
served hyperglycemia and postischemic renal dysfunction. 
The data further suggest that lactate alone is not the pre- 
dominant effector of ischemic injury in conditions of eu- 
glycemia and mild hypoglycemia. 
In summary, hyperglycemia-exacerbated postischemic 
renal dysfunction is demonstrated. Insulin-induced re- 
duction of plasma glucose failed to protect in this model. 
Finally, while insulin-induced reduction of tissue lactate 
did not reduce postischemic renal dysfunction, marked 
lactate accumulation may contribute to the marked ex- 
acerbation of dysfunction following exogenous glucose 
administration. 
Clinical applications. Surgeons commonly deal with 
several settings in which renal ischemia is, a predictable 
consequence of the operative procedure, e.g., suprarenal 
aortic clamp and renal transplantation. In other settings, 
such as “routine” aortic surgery or resuscitation from 
shock and trauma, renal ischemic considerations are less 
obvious but equally important. Optimal support of isch- 
emit tissues has not been fully defined. Of clear impor- 
tance is the need for an ongoing energy supply to continue 
essential cellular processes, yet continued glucose metab- 
olism during ischemia seems to clearly be detrimental. 
The precise role of metabolic factors in renal ischemia 
are of critical importance to the understanding of organ 
injury. Delineation may provide potential loci for effec- 
tively altering metabolism to achieve protection from ir- 
reversible injury. 
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